Section 182-52-0015 - Prescription drug affordability board-Board members(1) The prescription drug affordability board has five governor-appointed members with expertise in health care economics or clinical medicine. Once appointed, board members serve a five-year term.(2) The governor may reappoint board members for additional terms.(3) Board members cannot be an employee of, a board member of, or a consultant to any of the following: (a) Prescription drug manufacturer;(b) Pharmacy benefit manager;(d) Prescription drug wholesale distributor; or(e) Trade association related to (a) through (d) of this subsection.(4) Board members can be replaced or removed under the following circumstances including, but not limited to: (a) Failure to participate;(b) Unprofessional/unethical behavior; or(c) Conflict of interest.(5) If a board member violates subsection (3) or (4) of this section or other board established policies, the member may be removed from the board.(6) Following appointment, board members must submit a conflict of interest disclosure form provided by the authority. The conflict of interest disclosure form must be submitted on an annual basis by July 1st of each year while the member is active with the board. Board members must keep their disclosure statements current and provide updated information within 30 calendar days whenever circumstances change.(7) Board members must recuse themselves from any board activity in which they have a conflict of interest or the appearance of a conflict of interest, whether or not it is disclosed in the conflict of interest disclosure form.(8) Following appointment and prior to participating in board activities, board members must enter into a personal services contract with the authority to be compensated for participation in the work of the board.Wash. Admin. Code § 182-52-0015
Adopted by WSR 24-02-078, Filed 1/2/2024, effective 6/10/2024